NCT02613884View on ClinicalTrials.gov

Safety, Efficacy, and Feasibility of High-dose Cholecalciferol in Pediatric Patients With Cystic Fibrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

November 25, 2019

Study Completion Date

November 25, 2019

Conditions
Vitamin D Deficiency
Interventions
DRUG

Treatment

Trial Locations (1)

33701

Johns Hopkins All Children's Hospital, St. Petersburg

All Listed Sponsors
lead

Johns Hopkins All Children's Hospital

OTHER

NCT02613884 - Safety, Efficacy, and Feasibility of High-dose Cholecalciferol in Pediatric Patients With Cystic Fibrosis | Biotech Hunter | Biotech Hunter